The relationship between gender and pharmacology.

Area of Science:

• Biomedical Research
• Pharmacology
• Sexuality in Science

Background:

• Historical underrepresentation of female models in preclinical research.
• Sexuality bias impacts disease understanding and treatment disparities.
• Lack of acknowledgment of sexuality as a determinant in drug efficacy.

Purpose of the Study:

• To review the role of sexuality in biomedical research.
• To analyze the impact of sexuality on pharmacological studies.
• To identify potential risks associated with gender bias in drug development.

Main Methods:

• Literature review of preclinical studies.
• Analysis of research methodologies concerning sex as a biological variable.
• Examination of existing data on gender differences in disease and drug response.

Main Results:

• Significant disparities exist in the understanding and treatment of diseases between genders due to historical bias.
• Sexuality bias limits the interpretation and replicability of preclinical research findings.
• Progress in including female models is noted, but disparities persist.

Conclusions:

• Sexuality is a critical biological variable in biomedical and pharmacological research.
• Addressing sex bias is essential for ensuring the safety, efficacy, and equitable application of therapeutic agents.
• Further research and inclusive methodologies are needed to overcome gender disparities in health outcomes.